These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 19148858

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.
    Patel RR.
    Cardiol Rev; 2009; 17(3):132-5. PubMed ID: 19384087
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.
    Irons BK, Greene RS, Mazzolini TA, Edwards KL, Sleeper RB.
    Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Heart failure while taking glitazones--what do we know today?].
    Halbritter R.
    Dtsch Med Wochenschr; 2009 Jul; 134(28-29):1488; author reply 1488. PubMed ID: 19572255
    [No Abstract] [Full Text] [Related]

  • 8. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U, Pop-Busui R, Eagle KA.
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [Abstract] [Full Text] [Related]

  • 9. [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].
    De Flines J, Scheen AJ.
    Rev Med Suisse; 2007 Aug 29; 3(122):1876, 1878-83. PubMed ID: 17896661
    [Abstract] [Full Text] [Related]

  • 10. The role of glitazones in management of type 2 diabetes. A dream or a nightmare?
    Lindberg M, Astrup A.
    Obes Rev; 2007 Sep 29; 8(5):381-4. PubMed ID: 17716295
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality.
    Stafylas PC, Sarafidis PA, Lasaridis AN.
    Int J Cardiol; 2009 Jan 24; 131(3):298-304. PubMed ID: 18684530
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
    Dahabreh IJ, Economopoulos K.
    Clin Trials; 2008 Jan 24; 5(2):116-20. PubMed ID: 18375649
    [Abstract] [Full Text] [Related]

  • 15. Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study.
    Hartung DM, Touchette DR, Bultemeier NC, Haxby DG.
    Pharmacotherapy; 2005 Oct 24; 25(10):1329-36. PubMed ID: 16185176
    [Abstract] [Full Text] [Related]

  • 16. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan 24; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 17. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
    Krentz A.
    Diabetes Metab Res Rev; 2009 Feb 24; 25(2):112-26. PubMed ID: 19219860
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular risk and cardiometabolic protection: role of glitazones.
    Petrazzi L, Grassi D, Polidoro L, D'Aurelio A, Croce G, Properzi G, Tiberti S, Desideri G, Ferri C.
    J Nephrol; 2008 Feb 24; 21(6):826-35. PubMed ID: 19034866
    [Abstract] [Full Text] [Related]

  • 19. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS.
    Acta Diabetol; 2009 Jun 24; 46(2):145-54. PubMed ID: 19194648
    [Abstract] [Full Text] [Related]

  • 20. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ, Tenenbaum A, Motro M, Adler Y.
    Herz; 2004 May 24; 29(3):290-8. PubMed ID: 15167955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.